Pfizer, Inc. (PFE)

37.6 -0.61%
01:57 pm EDT; Powered by Koyfin
Pros
Stock price low relative to the 52-week range
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/B ratio low relative to industry peers
Forward P/S ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages

Pros

  1. PFE stock price ($39.21) is close to the 52-week low ($38.63). Perhaps now is a good time to buy? See PFE price chart.
  2. PFE profitability is improving. The YoY profit margin change was 26.89 percentage points. See PFE profitability chart.
  3. PFE forward dividend yield is 4.23%, higher than the industry (2.22%) and sector (0.21%) forward dividend yields. See PFE forward dividend chart.
  4. PFE Price/Book ratio is 2.28, which is low compared to its industry peers’ P/B ratios. See PFE forward Price/Book ratio chart.
  5. PFE Price/Sales ratio is 2.19, which is low compared to its industry peers’ P/S ratios. See PFE forward Price/Sales ratio chart.
  6. PFE average analyst rating is Buy. See PFE analyst rating chart.
  7. PFE average analyst price target ($55.88) is above its current price ($39.21). See PFE price target chart.

Cons

  1. PFE quarterly revenue growth was 1.90%, lower than the industry and sector average revenue growth (7.80% and 3.00%, respectively). See PFE revenue growth chart.